payers

“But the reality is payers aren't cost cutters. They're assessors of value. And if you have transformative drugs, or if you can transform how we think about diagnosing and screening disease, the payers are willing to pay for that value.”

“The payers probably have more and better real-world data than the pharma companies do, and one of the reasons that the pharma companies will eventually, in my opinion, have to do data sharing, as Andrew suggests, is that the payers are going to aggregate their…”

“It's really the payers and some of the clinicians that are being the inhibitors to this progress.”

“If you're looking at the average statistics, generally when you're launching a diagnostic test, only about 20% of the tests that you sell actually get fully reimbursed.”

“Either you're going to go after providers or payers. You're rarely going to do both as a startup.”

“If we're gonna make this widely accessible to patients that need them, it's gonna have to be affordable. So we'll need new models for how pharmaceutical companies charge for this, and we're seeing early days of this. We're going to need new models for how paye…”

“While B to C to B can be more complex to execute, it gives startups the power to acquire and engage users directly without first contracting with the payer.”

“Now with virtual care we are a normal product. It is a normal clinical service, and it is in the eyes of a payer. They know how to pay for these types of services.”

“For example, if you needed to control and in your care model, you know, all of utilization management, you know, the claims payment network design. Well, there's probably no other way for a payer to let you have those keys other than moving to a true global ca…”

“So you call the same payer twice for the same patient, and you will get different answers 25% of the time.”